| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Yealland G et al. | Rescue of mitochondrial function in parkin-mutant fibroblasts using drug loaded PMPC-PDPA polymersomes and tubular polymersomes. | 2016 | Neurosci. Lett. | pmid:27412236 |
| Renga B et al. | Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids. | 2015 | Am. J. Physiol. Heart Circ. Physiol. | pmid:25934094 |
| Jung JI et al. | Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator. | 2015 | Mol Neurodegener | pmid:26169917 |
| Luengo-Alonso C et al. | A novel performing PEG-cholane nanoformulation for Amphotericin B delivery. | 2015 | Int J Pharm | pmid:26319629 |
| Coufalová L et al. | New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers. | 2013 | Steroids | pmid:23435200 |
| Mrózek L et al. | New polyfluorothiopropanoyloxy derivatives of 5β-cholan-24-oic acid designed as drug absorption modifiers. | 2013 | Steroids | pmid:23707574 |
| Russo S et al. | Synthesis and structure-activity relationships of amino acid conjugates of cholanic acid as antagonists of the EphA2 receptor. | 2013 | Molecules | pmid:24152675 |
| Mortiboys H et al. | Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease. | 2013 | Brain | pmid:24000005 |
| Na JH et al. | Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency. | 2012 | J Control Release | pmid:22846988 |
| Heibein AD et al. | Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization. | 2012 | BMC Cancer | pmid:22938713 |
| Bajaj G et al. | Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release. | 2012 | PLoS ONE | pmid:22292072 |
| Tognolini M et al. | Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor. | 2012 | ChemMedChem | pmid:22529030 |
| Bukiya AN et al. | Calcium- and voltage-gated potassium (BK) channel activators in the 5β-cholanic acid-3α-ol analogue series with modifications in the lateral chain. | 2012 | ChemMedChem | pmid:22945504 |
| Krasowski MD et al. | The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species. | 2011 | BMC Biochem. | pmid:21291553 |
| Wang JJ et al. | Recent advances of chitosan nanoparticles as drug carriers. | 2011 | Int J Nanomedicine | pmid:21589644 |
| Banerjee D et al. | Nanotechnology-mediated targeting of tumor angiogenesis. | 2011 | pmid:21349160 | |
| Lian H et al. | Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery. | 2011 | Int J Nanomedicine | pmid:22228999 |
| Tong Z et al. | In vitro metabolism and identification of human enzymes involved in the metabolism of methylnaltrexone. | 2010 | Drug Metab. Dispos. | pmid:20173089 |
| Nam T et al. | Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging. | 2010 | Bioconjug. Chem. | pmid:20201550 |
| Li T et al. | Use of glycol chitosan modified by 5beta-cholanic acid nanoparticles for the sustained release of proteins during murine embryonic limb skeletogenesis. | 2010 | J Control Release | pmid:20116406 |
| Huh MS et al. | Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. | 2010 | J Control Release | pmid:20184928 |
| Bukiya AN et al. | Structural determinants of monohydroxylated bile acids to activate beta 1 subunit-containing BK channels. | 2008 | J. Lipid Res. | pmid:18650555 |
| Suzuki T et al. | The novel compounds that activate farnesoid X receptor: the diversity of their effects on gene expression. | 2008 | J. Pharmacol. Sci. | pmid:18603830 |
| Hembruff SL et al. | Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance. | 2008 | BMC Cancer | pmid:18980695 |
| Sephton MA et al. | Biomedical and forensic applications of combined catalytic hydrogenation-stable isotope ratio analysis. | 2007 | Anal Chem Insights | pmid:19662175 |
| Posa M et al. | Determination of critical micellar concentrations of cholic acid and its keto derivatives. | 2007 | Colloids Surf B Biointerfaces | pmid:17604970 |
| Suri SS et al. | Nanotechnology-based drug delivery systems. | 2007 | J Occup Med Toxicol | pmid:18053152 |
| Endo S et al. | Characterization of an oligomeric carbonyl reductase of dog liver: its identity with peroxisomal tetrameric carbonyl reductase. | 2007 | Biol. Pharm. Bull. | pmid:17827741 |
| Park K et al. | Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. | 2007 | J Control Release | pmid:17643545 |
| Kim JH et al. | Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. | 2006 | J Control Release | pmid:16458988 |
| Steckelbroeck S et al. | Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily. | 2006 | J. Pharmacol. Exp. Ther. | pmid:16339391 |
| Kikolski EM et al. | (-)-3,7-Dioxo-5beta-cholanic acid: dual hydrogen-bonding modes in a diketonic bile-acid derivative. | 2006 | Acta Crystallogr C | pmid:16823211 |
| Bottari E et al. | Composition of sodium cholate micellar solutions. | 2005 Jul-Aug | Ann Chim | pmid:16235782 |
| Adachi R et al. | Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. | 2005 | J. Lipid Res. | pmid:15489543 |
| Fukuchi J et al. | 5beta-Cholane activators of the farnesol X receptor. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:15857750 |
| Ledeboer NA and Jones BD | Exopolysaccharide sugars contribute to biofilm formation by Salmonella enterica serovar typhimurium on HEp-2 cells and chicken intestinal epithelium. | 2005 | J. Bacteriol. | pmid:15838049 |
| Park JH et al. | Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery. | 2004 | J Control Release | pmid:15023468 |
| Tochtrop GP et al. | Synthesis of [3,4-(13)c(2)]-enriched bile salts as NMR probes of protein-ligand interactions. | 2002 | J. Org. Chem. | pmid:12227809 |
| Ivanova A et al. | Transformation of cholanic acid derivatives into pharmacologically active esters of phenolic acids by heterogeneous Wittig reaction. | 1997 Jul-Aug | Z. Naturforsch., C, J. Biosci. | pmid:9309880 |
| Dayal B et al. | Microwave-induced organic reactions of bile acids: esterification, deformylation and deacetylation using mild reagents. | 1995 | Steroids | pmid:7676478 |
| Chevrie K et al. | Dye-hydrophobic hapten conjugate/anti-dye antibody complex as immunogen: preparation of hydrophobic hapten-specific monoclonal antibodies. | 1994 | Biochimie | pmid:8043652 |
| Sqalli-Houssaini H et al. | Preparation of anti-HIV-low-density lipoprotein complexes for delivery of anti-HIV drugs via the low-density lipoprotein pathways. | 1994 | Biotechnol Ther | pmid:7703834 |
| Campanella L et al. | Cholanic acids determined in commercial drugs by means of a new ISFET device. | 1993 Nov-Dec | J Pharm Biomed Anal | pmid:8123735 |
| Fantin G et al. | Synthesis of 7- and 12-hydroxy- and 7,12-dihydroxy-3-keto-5 beta-cholan-24-oic acids by reduction of 3,7-, 3,12- and 3,7,12-oxo derivatives. | 1993 | Steroids | pmid:8273114 |
| Yoshimura T et al. | An efficient synthesis of 4 beta- and 6 alpha-hydroxylated bile acids. | 1993 | Steroids | pmid:8484184 |
| Mori Y et al. | Absence of mutagenic action of 5 beta-cholan-24-oic acid derivatives in the bacterial fluctuation and standard Ames tests. | 1991 | Mutat. Res. | pmid:2017224 |
| Allevi P et al. | Synthesis of 7 alpha,12 alpha-dihydroxy-3 alpha- [2-(beta-D-glucopyranosyl)acetyl]-5 beta-cholan-24-oic acid. | 1990 | Steroids | pmid:2219197 |
| Sawada K et al. | Promoting effect of 5 beta-chol-3-en-24-oic acid on N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats. | 1987 | Jpn. J. Cancer Res. | pmid:3117746 |
| Eto T and Tompkins RK | Further studies on the inhibition of pepsin by bile salts. | 1986 | Ann. Surg. | pmid:3079997 |
| Lawson AM et al. | Rapid diagnosis of Zellweger syndrome and infantile Refsum's disease by fast atom bombardment--mass spectrometry of urine bile salts. | 1986 | Clin. Chim. Acta | pmid:2433077 |
| Waterhous DV et al. | Nuclear magnetic resonance spectroscopy of bile acids. Development of two-dimensional NMR methods for the elucidation of proton resonance assignments for five common hydroxylated bile acids, and their parent bile acid, 5 beta-cholanoic acid. | 1985 | J. Lipid Res. | pmid:4067429 |
| Ganitkevich IaV | [Cellular and molecular mechanisms of the physiological action of bile acids]. | 1984 Oct-Dec | Usp Fiziol Nauk | pmid:6095555 |
| Dodd NK et al. | Cholanoic acids and cholesterol 7-alpha-hydroxylase activity in human leucocytes. | 1982 | Biochem. Biophys. Res. Commun. | pmid:7103999 |
| Roseleur OJ and van Gent CM | A simplified method for the determination of steroids in diets and faeces. | 1978 | Clin. Chim. Acta | pmid:618675 |
| THOMAS PJ et al. | BILE ACIDS. XXI. METABOLISM OF 3-ALPHA,6-BETA-DIHYDROXY-5-BETA-CHOLANOIC ACID-24-C 14-6-ALPHA-H3 IN THE RAT. | 1965 | J. Biol. Chem. | pmid:14284702 |
| DANIELSSON H et al. | ON THE COMPOSITION OF THE BILE ACID FRACTION OF RABBIT FECES AND THE ISOLATION OF A NEW BILE ACID: 3-ALPHA, 12-ALPHA-DIHYDROXY-5-ALPHA-CHOLANIC ACID. BILE ACIDS AND STEROIDS. 136. | 1963 | J. Biol. Chem. | pmid:14086715 |
| DANIELSSON H et al. | Synthesis of some 3beta-hydroxylated bile acids and the isolation of 3beta, 12alpha-dihydroxy-5beta-cholanic acid from feces. | 1962 | J. Biol. Chem. | pmid:14024950 |
| RAY PD et al. | Bile acids. XVI. Metabolism of cholanic acid-24-C-14 in the rat. | 1961 | J. Biol. Chem. | pmid:14490705 |
| RUDMAN D and KENDALL FE | Bile acid content of human serum. II. The binding of cholanic acids by human plasma proteins. | 1957 | J. Clin. Invest. | pmid:13416382 |
| pmid: | ||||
| pmid:19331853 | ||||
| pmid:18374444 | ||||
| pmid:18336946 | ||||
| pmid:18289669 | ||||
| pmid:18234388 | ||||
| pmid:15710514 | ||||
| pmid:26607331 | ||||
| pmid:13282735 | ||||
| pmid:24819990 | ||||
| pmid:15667177 |
5beta-Cholanoic acid
5beta-cholanoic acid is a lipid of Sterol Lipids (ST) class. The involved functions are known as Vasodilation and Intestinal Absorption. The associated genes with 5beta-Cholanoic acid are iberiotoxin.
Cross Reference
Introduction
To understand associated biological information of 5beta-Cholanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 5beta-Cholanoic acid?
There are no associated biomedical information in the current reference collection.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with 5beta-Cholanoic acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 5beta-Cholanoic acid?
There are no associated biomedical information in the current reference collection.
What functions are associated with 5beta-Cholanoic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 5beta-Cholanoic acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with 5beta-Cholanoic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 5beta-Cholanoic acid?
There are no associated biomedical information in the current reference collection.